Odyssey Health, Inc. (OTCMKTS:ODYY – Get Free Report) saw a large growth in short interest in September. As of September 15th, there was short interest totaling 61,842 shares, a growth of 247.8% from the August 31st total of 17,779 shares. Based on an average daily volume of 253,473 shares, the days-to-cover ratio is currently 0.2 days.
Odyssey Health Stock Performance
Shares of ODYY traded up $0.00 during trading hours on Friday, hitting $0.01. The stock had a trading volume of 1,600 shares, compared to its average volume of 171,240. The firm has a 50 day simple moving average of $0.01 and a 200-day simple moving average of $0.03. Odyssey Health has a 1-year low of $0.00 and a 1-year high of $0.12.
About Odyssey Health
Odyssey Health, Inc is a medical technology company focused on developing and commercializing products intended to address neurological and other health conditions. The company’s activities have centered on the development of therapeutic and diagnostic solutions designed to support improved patient outcomes.
Odyssey Health has described a product pipeline addressing conditions including concussion and mild traumatic brain injury, migraine headaches, and stroke-related impairment. Its development programs have included pharmaceutical and medical-device approaches, although the availability and regulatory status of individual products may vary.
The company was previously known as Odyssey Group International, Inc and adopted the Odyssey Health name as part of its focus on healthcare and medical technology.
See Also
- Five stocks we like better than Odyssey Health
- Data Centers Got the AI Hype—But Office REITs May Get the Rent Hikes
- 2 Cybersecurity Stocks Breaking Out as AI Continues to Be a Tailwind
- 3 More AI Infrastructure Plays Beyond the Big Names
- CAVA Stock Slips: Sector Fear or Valuation Reality?
Receive News & Ratings for Odyssey Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Odyssey Health and related companies with MarketBeat.com's FREE daily email newsletter.
